Activity of systemic inflammatory reaction in patients with chronic obstructive pulmonary disease in regard to small intestinal absorption function

Terapevticheskii Arkhiv

Volumn 81, Issue 3, 2009, Pages 19-23

  Beloborodova, E I ^a   Akimova, L A ^a   Burkovskaya, V A ^a   Asanova, A V ^a   Semenenko, E V ^a  

^a NONE

Author keywords

Chronic obstructive pulmonary disease; Intestinal absorption; Systemic inflamation

Indexed keywords

CARBOHYDRATE; FAT; PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; HUMAN; INFLAMMATION; INTESTINE ABSORPTION; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SMALL INTESTINE;

ADULT; AGED; CARBOHYDRATES; FATS; FEMALE; HUMANS; INFLAMMATION; INTESTINAL ABSORPTION; INTESTINE, SMALL; MALE; MIDDLE AGED; PROTEINS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67449113496     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/ WHO Workshop report. Last updated 2006. www.goldcopd.org/.
2. HahmoH I. Morrtaon D., Donaldaon K. MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am. J. Respir. Grit. Gate Med. 1996; 154: 1055-1060.
3. MacNee W. Oxidative stress and lung inflammation in airways disease. Eur. J. Pharmacol. 2001; 429: 195-207.
4. Burnett D. Hill S. L., Chamba A., Stockley R. A. Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet 1987; 2: 1043-1046.
5. Jeffery P. K. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax 1998, 53: 129-136.
6. Saetta M., Baraldo S., Corbino L. et al. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 160: 711-717.
7. Di Francia M., Barbier D., Mege J. L, Orehek J. Tumor necrosis factor - alpha levels and weijght loss in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1994; 150: 1453-1455.
8. Agusti A. G. Systemic effects of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2005; 2: 367-370.
9. Dahl M., Vestbo J., Lange P. et al. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2007; 175: 250-255.
10. Pinto-Plata V. M., Mullerova H., Toso J. F. et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 1998; 61: 23-28.
11. Agusti A. G. N., Noguera A., Sauleda J. et al. Systemic effects of chronic obstructive pulmonary disease. Eur. Respir. J. 2003; 21: 347-360.
12. Gan W. Q., Man S. F., Senthilsehan A., Sin D. D. The association between chronic obstructive pulmonary disease and systemic inflammation a systematic review and a meta-analysis. Thorax 2004; 59: 574-580.
13. Beriies J., Viswanathan V. K., Savkovic S. D., Hecht G. Intestinal epithelial responses to enteric pathogens: effects on tight junction barrier, ion transport, and inflammation. Gut 2003; 52: 439-451.
14. Perdue M. H. Mucosal Immunity and inflammation. III. The mucosal antigen barrier: cross talk with mucosal cytokines. Am. J. Physiol. Gastrointest. Liver Physio;. 1999; 277: 1-5.
15. McKay D. M., Baird A. W. Cytokine regulation of epithelial permeability and ion transport. Gut 1999; 44: 283-289.
16. Elliott S. J., O'Connell C. B., Koutsouris A. et al. A gene from the locus of enterocyte effacement that is required for enter-opathogenic E. coli to increase tight-junction permeability encodes a chaperone for EspF. Infect, and Immun. 2002; 70: 2271-2277.
17. Fasano A. Toxins and the gut: role in human disease. Gut 2002; 50: 9-14.
18. Fleckenstein J. M., Kopecko D. J. Breaching the mucosal barier by stealth: an emerging pathogenic mechanism for enteroad-herent bacterial pathogens. J. Clin. Invest. 2001; 107: 27-30.
19. Van De Kamer J. H., Bokkel Hunink H. Weyer H. A rapid method for the determination of fat in feces. J. Biol. Chem. 1949; 177: 347-355.
20. Roe J. H., Rice E. W. A photometric method for the determination of free pentoses animal fissues. J. Biol. Chem. 1948; 173 (2): 507-512.
21. Agusti A. G. N. Sauleda J., Miralles C. et al. Skeletal muscle apoptosis and weight loss in COPD. Am. J. Respir. Crit. Care Med. 2002; 166: 485-489.
22. Petrache L, Otterbein L. E., Alam J. et al. Heme oxygenase - I inhibis TNF-α -induced apoptosis in cultured fibroblasts. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000; 278: 312-319.
23. Adams V., Jiang H., Yu J. et al. Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance. J. Am. Coll. Cardiol. 1999; 33: 959-965.
24. Vescovo G., Volterrani M., Zennaro R. et al. Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes. Heart 2000; 84: 431-437.
25. Gosker N. R., Wouters E. F. M., Van der Vusse G. L., Schols A. M. W. J. Skeletal muscle dysftinction in COPD and chronic heart failure: underlying mechanisms and therapy perspectives. Am. J. Clin. Nutr. 2000; 71: 1033-1047.
26. Fourman L. P. R. Absorption of xylose in steatorrhea. Clin. Sci. 1948; 4: 289-294.